Skip to main content
. 2010 Dec;51(12):3443–3454. doi: 10.1194/jlr.M008706

Fig. 1.

Fig. 1.

[3H]cholesteryl ester-labeled HDL3 was incubated with unlabeled HDL2 and recombinant human cholesteryl ester transfer protein [(rh)CETP] in the presence of: (A) dalcetrapib, 0.01 µM to 10 µM (n = 3); (B) dalcetrapib, 1 µM and 10 µM, torcetrapib and anacetrapib, 0.001 µM to 10 µM (n = 4–6). Data are expressed as radioactivity recovered in the HDL2 fraction as a percentage of total radioactivity [mean (SD)]. Blank value: without added rhCETP; control value: with added rhCETP. (*P < 0.01 vs. control, Student's t-test; #P < 0.01 vs. control, Dunnett test).

HHS Vulnerability Disclosure